CompanyDrug

Priority Review Status Anticipated for HH-003, BI655130, VIS649, and Remternetug by CDE

CompanyDrug

Bristol-Myers Squibb Launches Zeposia in China for Multiple Sclerosis Treatment

Policy / Regulatory

Hubei Implements Inter-Provincial VBP Tender Results for Pacemakers

CompanyDrug

Zelgen Biopharmaceuticals’ ZG006 Earns FDA Approval for Small-Cell Lung Cancer Trial

CompanyDrug

JW Therapeutics’ Carteyva Receives NMPA Approval for Moderate-to-Severe SLE Clinical Trial

CompanyDeals

Hua Medicine Partners with 111 Inc. for Dorzagliatin Sales and Distribution in China

Company

CStone Pharmaceuticals Reduces Ayvakit Price to Boost Accessibility in China

CompanyDeals

Hangzhou Baikai Biomedical and Leads Biolabs Partner to Develop Innovative ADCs

HospitalPolicy / Regulatory

NHC Report: Performance Assessment of National Class 2 Public Hospitals in 2021

CompanyDeals

Cuban-Chinese Biotechnology Center Showcases Drug and Vaccine Progress to Cuban Delegation

Medical DevicePolicy / Regulatory

Hebei Leads Sanming Alliance in Launching 8th VBP for 19 Medical Consumables

CompanyDrug

Takeda Pharma’s Iclusig Poised for Priority Review by CDE for Leukemia Treatments